Anti-Mullerian Hormone

"Anti-Mullerian Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.

Descriptor ID	D054304
MeSH Number(s)	D06.472.334.984.500
Concept/Terms	Anti-Mullerian Hormone Anti-Mullerian Hormone Anti Mullerian Hormone Antimullerian Hormone Mullerian Inhibiting Hormone Mullerian Inhibiting Substance Mullerian-Inhibitory Substance Mullerian Inhibitory Substance Mullerian-Inhibiting Factor Mullerian Inhibiting Factor Mullerian-Inhibiting Hormone Anti-Mullerian Factor Anti Mullerian Factor Mullerian Regression Factor

Below are MeSH descriptors whose meaning is more general than "Anti-Mullerian Hormone".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Gonadal Hormones [D06.472.334]
Testicular Hormones [D06.472.334.984]
Anti-Mullerian Hormone [D06.472.334.984.500]

Below are MeSH descriptors whose meaning is related to "Anti-Mullerian Hormone".

Below are MeSH descriptors whose meaning is more specific than "Anti-Mullerian Hormone".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-Mullerian Hormone" by people in this website by year, and whether "Anti-Mullerian Hormone" was a major or minor topic of these publications.

Bar chart showing 43 publications over 17 distinct years, with a maximum of 8 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	2	2
1994	0	2	2
1997	0	1	1
2002	0	2	2
2003	0	5	5
2004	0	4	4
2007	0	1	1
2012	1	0	1
2014	1	0	1
2015	1	0	1
2016	0	1	1
2017	1	0	1
2018	2	1	3
2019	2	1	3
2020	3	1	4
2021	7	1	8
2022	2	1	3

Below are the most recent publications written about "Anti-Mullerian Hormone" by people in Profiles.

Grimes NP, Whitcomb BW, Reeves KW, Sievert LL, Purdue-Smithe A, Manson JE, Hankinson SE, Rosner BA, Bertone-Johnson ER. The association between anthropometric factors and anti-Müllerian hormone levels in premenopausal women. Women Health. 2022 08; 62(7):580-592.

View in: PubMed
Grimes NP, Bertone-Johnson ER, Whitcomb BW, Sievert LL, Crawford SL, Gold EB, Avis NE, Greendale GA, Santoro N, Habel LA, Reeves KW. Anti-Müllerian hormone levels and breast cancer risk in the study of women's health across the nation. Cancer Causes Control. 2022 Aug; 33(8):1039-1046.

View in: PubMed
Zhou B, Kwan B, Desai MJ, Nalawade V, Ruddy KJ, Nathan PC, Henk HJ, Murphy JD, Whitcomb BW, Su HI. Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors. Fertil Steril. 2022 05; 117(5):1047-1056.

View in: PubMed
Langton CR, Whitcomb BW, Purdue-Smithe AC, Sievert LL, Hankinson SE, Manson JE, Rosner BA, Bertone-Johnson ER. Association of oral contraceptives and tubal ligation with antimüllerian hormone. Menopause. 2021 12 06; 29(2):225-230.

View in: PubMed
Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Bertone-Johnson E, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Liu M, Zeleniuch-Jacquotte A. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4542-e4553.

View in: PubMed
Grimes NP, Whitcomb BW, Reeves KW, Sievert LL, Purdue-Smithe A, Manson JE, Hankinson SE, Rosner BA, Bertone-Johnson ER. The association of parity and breastfeeding with anti-Müllerian hormone levels at two time points. Maturitas. 2022 Jan; 155:1-7.

View in: PubMed
Sacha CR, Souter I, Williams PL, Chavarro JE, Ford J, Mahalingaiah S, Donahoe PK, Hauser R, Pépin D, Mínguez-Alarcón L. Urinary phthalate metabolite concentrations are negatively associated with follicular fluid anti-müllerian hormone concentrations in women undergoing fertility treatment. Environ Int. 2021 12; 157:106809.

View in: PubMed
Meinsohn MC, Saatcioglu HD, Wei L, Li Y, Horn H, Chauvin M, Kano M, Nguyen NMP, Nagykery N, Kashiwagi A, Samore WR, Wang D, Oliva E, Gao G, Morris ME, Donahoe PK, Pépin D. Single-cell sequencing reveals suppressive transcriptional programs regulated by MIS/AMH in neonatal ovaries. Proc Natl Acad Sci U S A. 2021 05 18; 118(20).

View in: PubMed
Vagios S, Sacha CR, Hammer KC, Dimitriadis I, James KE, Bormann CL, Souter I. Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-Müllerian hormone levels. J Assist Reprod Genet. 2021 Jul; 38(7):1827-1833.

View in: PubMed
Vagios S, Hsu JY, Sacha CR, Dimitriadis I, Christou G, James KE, Bormann CL, Souter I. Pretreatment antimüllerian hormone levels and outcomes of ovarian stimulation with gonadotropins/intrauterine insemination cycles. Fertil Steril. 2021 08; 116(2):422-430.

View in: PubMed

People

Explore

Similar Concepts

Top Journals